Allarity Therapeutics, Inc. Retained Earnings
Allarity Therapeutics, Inc. (ALLR) had Retained Earnings of -$136.35 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$136.35M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$132.95M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$130.20M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$126.82M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$136.35M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$132.95M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$130.20M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$126.82M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$124.02M 10-Q · filed 2025-08-15 | |
| 2025-03-31 | -$121.70M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | -$118.97M 10-K · filed 2026-03-30 | |
| 2024-09-30 | -$111.51M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$99.92M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | -$98.29M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | -$94.45M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$92.73M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$88.28M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$85.90M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$82.55M 10-K · filed 2024-03-08 | |
| 2022-09-30 | -$79.71M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$74.67M 10-Q · filed 2022-10-07 | |
| 2022-03-31 | -$69.57M 10-Q · filed 2022-05-27 | |
| 2021-12-31 | -$66.49M 10-K · filed 2023-03-13 | |
| 2021-09-30 | -$49.68M 10-Q/A · filed 2022-05-17 | -$43.42M 10-Q · filed 2021-11-23 |
| 2020-12-31 | -$39.84M 10-Q/A · filed 2022-05-17 | -$37.43M 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |